|
1
|
Fu Q, Gao N, Yu J, Ma G, Du Y, Wang F, Su
Q and Che F: Diazoxide pretreatment prevents Aβ1-42 induced
oxidative stress in cholinergic neurons via alleviating NOX2
expression. Neurochem Res. 39:1313–1321. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mota SI, Ferreira IL and Rego AC:
Dysfunctional synapse in Alzheimer's disease-A focus on NMDA
receptors. Neuropharmacology. 76:16–26. 2014. View Article : Google Scholar
|
|
3
|
Roselli F, Tirard M, Lu J, Hutzler P,
Lamberti P, Livrea P, Morabito M and Almeida OF: Soluble
beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic
density-95 at glutamatergic synapses. J Neurosci. 25:11061–11070.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Parameshwaran K, Dhanasekaran M and
Suppiramaniam V: Amyloid beta peptides and glutamatergic synaptic
dysregulation. Exp Neurol. 210:7–13. 2008. View Article : Google Scholar
|
|
5
|
Ferreira IL, Bajouco LM, Mota SI, Auberson
YP, Oliveira CR and Rego AC: Amyloid beta peptide 1-42 disturbs
intracellular calcium homeostasis through activation of
GluN2B-containing N-methyl-d-aspartate receptors in cortical
cultures. Cell Calcium. 51:95–106. 2012. View Article : Google Scholar
|
|
6
|
Ronicke R, Mikhaylova M, Rönicke S,
Meinhardt J, Schröder UH, Fändrich M, Reiser G, Kreutz MR and
Reymann KG: Early neuronal dysfunction by amyloid β oligomers
depends on activation of NR2B-containing NMDA receptors. Neurobiol
Aging. 32:2219–2228. 2011. View Article : Google Scholar
|
|
7
|
Loftis JM and Janousky A: The
N-methyl-D-aspartate receptor subunit NR2B: Localization, function
properties, regulation and clinical implication. Pharmacol Ther.
97:55–85. 2003. View Article : Google Scholar
|
|
8
|
Virgili N, Mancera P, Wappenhans B,
Sorrosal G, Biber K, Pugliese M and Espinosa-Parrilla JF: K(ATP)
Channel opener diazoxide prevents neurodegeneration: A new
mechanism of action via antioxidative pathway activation. PLoS One.
8:e751892013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu D, Lu C, Wan R, Auyeung WW and Mattson
MP: Activation of mitochondrial ATP-dependent potassium channels
protects neurons against ischemia-induced death by a mechanism
involving suppression of Bax translocation and cytochrome c
release. J Cereb Blood Flow Metab. 22:431–443. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zeng X, Wang T, Jiang L, Ma G, Tan S, Li
J, Gao J, Liu K and Zhang Y: Diazoxide and cyclosporin A protect
primary cholinergic neurons against beta-amyloid (1-42)-induced
cytotoxicity. Neurol Res. 35:529–536. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ma G, Fu Q, Zhang Y, Gao J, Jiang J, Bi A,
Liu K, Du Y, Chen C, Cui Y and Lu L: Effects of Abeta1-42 on the
subunits of KATP expression in cultured primary rat basal forebrain
neurons. Neurochem Res. 33:1419–1424. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hardy J and Selkoe DJ: The amyloid
hypothesis of Alzheimer's disease: Progress and problems on the
road to therapeutics. Science. 297:353–356. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lacor PN, Buniel MC, Furlow PW, Clemente
AS, Velasco PT, Wood M, Viola KL and Klein WL: Abeta
oligomer-induced aberrations in synapse composition, shape and
density provide a molecular basis for loss of connectivity in
Alzheimer's disease. J Neurosci. 27:796–807. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Matos M, Augusto E, Oliveira CR and
Agostinho P: Amyloid-beta peptide decreases glutamate uptake in
cultured astrocytes: Involvement of oxidative stress and
mitogen-activated protein kinase cascades. Neuroscience.
156:898–910. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mattson MP, Cheng B, Davis D, Bryant K,
Lieberburg I and Rydel RE: beta-Amyloid peptides destabilize
calcium homeostasis and render human cortical neurons vulnerable to
excitotoxicity. J Neurosci. 12:376–389. 1992.PubMed/NCBI
|
|
16
|
Thomas CG, Miller AJ and Westbrook GL:
Synaptic and extra-synaptic NMDA receptor NR2 subunits in cultured
hippocampal neurons. J Neurophysiol. 95:1727–1734. 2006. View Article : Google Scholar
|
|
17
|
Köhr G, Jensen V, Koester HJ, Mihaljevic
AL, Utvik JK, Kvello A, Ottersen OP, Seeburg PH, Sprengel R and
Hvalby Ø: Intracellular domains of NMDA receptor subtypes are
determinants for long-term potentiation induction. J Neurosci.
23:10791–10799. 2003.PubMed/NCBI
|
|
18
|
Cais O, Sedlacek M, Horak M, Dittert I and
Vyklicky L Jr: Temperature dependence of NR1/NR2B NMDA receptor
channels. Neuroscience. 151:428–438. 2008. View Article : Google Scholar
|
|
19
|
Zempel H, Thies E, Mandelkow E and
Mandelkow EM: Abeta oligomers cause localized Ca(2+) elevation,
missorting of endogenous Tau into dendrites, Tau phosphorylation
and destruction of microtubules and spines. J Neurosci.
30:11938–11950. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tai KK, McCrossan ZA and Abbott GW:
Activation of mitochondrial ATP-sensitive potassium channels
increases cell viability against rotenone-induced cell death. J
Neurochem. 84:1193–1200. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Teshima Y, Akao M, Li RA, Chong TH,
Baumgartner WA, Johnston MV and Marbán E: MitoKATP channel
activation protects cerebellar granule neurons from apoptosis
induced by oxidative stress. Stroke. 34:1796–1802. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu D, Pitta M, Lee JH, Ray B, Lahiri DK,
Furukawa K, Mughal M, Jiang H, Villarreal J, Cutler RG, et al: The
KATP channel activator diazoxide ameliorates amyloid-β and Tau
pathologies and improves memory in the 3xTgAD mouse model of
Alzheimer's Disease. J Alzheimers Dis. 22:443–457. 2010.
|
|
23
|
Wickenden AD: K+ channels as therapeutic
drug targets. Pharmacol Ther. 94:157–182. 2002. View Article : Google Scholar : PubMed/NCBI
|
